WORLDWIDE CONTACT US ABOUT US INVENTING FOR LIFE PRODUCTS RESEARCH LICENSING NEWSROOM CAREERS INVESTORS Home Programs And Partnerships Our Policy Inclusive Recruitment Diversity and Career Development Training Partnerships Flexible Work Arrangements ONE MERCK DIVERSITY AND INCLUSION AWARD Established in 2006, this international, annual award celebrates and recognizes diversity and inclusion excellence at all levels, by individuals and teams, across Merck. Copyright. © 2009-2018 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. Forward-Looking Statement Privacy Terms of Use Site Map

WORLDWIDE CONTACT US ABOUT US INVENTING FOR LIFE PRODUCTS RESEARCH LICENSING NEWSROOM CAREERS INVESTORS Home A LEADER IN IMMUNO-ONCOLOGY CLINICAL RESEARCH We are investing significant resources to develop innovative oncology medicines to help people living with cancer. Merck is committed to bringing hope to people with cancer: 8 Eight different approved medicines and supportive care therapies that treat more than 12 different cancer types 700 + An oncology development program that includes more than 700 clinical trials ongoing and a pipeline of multiple novel mechanisms in pre-clinical and early phase development 40 + Partnerships with more than 40 companies or research institutions on our clinical research OUR INSPIRATION We believe in the work we do and are working with the entire cancer community to help people with cancer and their caregivers better navigate their journeys. Ultimately, our work in changing the outcomes of cancer would not be possible without: …the participation of patients in clinical trials …the support and involvement of the physicians who believe in the importance of advancing the care for patients through innovative clinical trials We’re pushing the boundaries of science with the hope and expectation that the medicines and vaccines we invent will lead to better health for society for generations to come. Learn more about how we're Inventing for Life Advancing Oncology Research Through Clinical Trials by Eric Rubin READ ERIC’S PERSPECTIVE Published April 2018 Copyright. © 2009-2018 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. Forward-Looking Statement Privacy Terms of Use Site Map